BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 17, 2014
View Archived Issues
Phase I results for MRX-34, a first-in-class liposome formulated miR-34 mimic
Read More
Sigma-Tau describes novel HSP 90 inhibitor
Read More
Interstitial deletion of 8p23.1 indicates a new causative gene for heterotaxy
Read More
Neuregulin-1 expression correlates with sensitivity to GDC-0032 PI3K inhibitor
Read More
Researchers present a novel method to predict the risk of rejection after heart transplant
Read More
Sym-013 augments response to lung and head and neck cancer tumors
Read More
Multiple studies examine treatment of HCV infection with veruprevir/ritonavir/ombitasvir combination
Read More
Karyopharm initiates phase I trial of selinexor and decitabine in AML
Read More
Kyowa Hakko Kirin begins phase III trials of benralizumab in Japan and South Korea
Read More
Prevention of PGE2-induced bladder overactivity by TRPM8 blocker DFL-23448
Read More
LDC and Daiichi Sankyo form early drug discovery alliance
Read More
OxThera receives financing to continue key clinical programs
Read More
SOM Biotech and Vall d'Hebron Research Institute team up to develop transthyretin amyloidosis drug
Read More
Dosing begins in phase I/II trial of APR-246 in ovarian cancer
Read More
Phase III trial of Baxter's BAX-111 achieves primary endpoint
Read More
Suglat tablets launched in Japan for type 2 diabetes
Read More
Iconic Therapeutics raises funding for development of AMD therapy
Read More
Epirus Biopharmaceuticals to merge with Zalicus
Read More
New anti-CD3 antibodies disclosed by Regeneron Pharmaceuticals
Read More
Researchers at the University of Washington design novel vaccines for viral infections
Read More
Bristol-Myers Squibb presents new XIAP inhibitors for cancer
Read More
Cleveland BioLabs announces results of CBL-0102 phase I cancer trial
Read More
Chugai to launch trastuzumab emtansine in Japan
Read More
Merck KGaA synthesizes novel FAS inhibitors
Read More
Effimune reports advances in the development of a new class of monoclonal antibodies
Read More
ViiV Healthcare launches dolutegravir in Japan
Read More